• 719-347-5400
  • info@realmofcaring.org
  • 719-347-5400
  • info@realmofcaring.org
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
Menu
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
  • Donate
  • Register
  • Login
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
Menu
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
  • Donate
  • Login

Research Library

A-Z Conditions  Participate in ORR

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

  • Journal : PLoSOne
  • Publication Year : 2011
  • Authors : Giuseppe Esposito; Caterina Scuderi; Marta Valenza; Giuseppina Ines Togna; Valentina Latina; Daniele De Filippis; Mariateresa Cipriano; Maria Rosaria Carratu; Teresa Iuvone; Luca Steardo

Peroxisome proliferator-activated receptor-c (PPARc) has been reported to be involved in the etiology of pathological features of Alzheimer’s disease (AD). Cannabidiol (CBD), a Cannabis derivative devoid of psychomimetic effects, has attracted much attention because of its promising neuroprotective properties in rat AD models, even though the mechanism responsible for such actions remains unknown. This study was aimed at exploring whether CBD effects could be subordinate to its activity at PPARc, which has been recently indicated as its putative binding site. CBD actions on bamyloid-induced neurotoxicity in rat AD models, either in presence or absence of PPAR antagonists were investigated. Results showed that the blockade of PPARc was able to significantly blunt CBD effects on reactive gliosis and subsequently on neuronal damage. Moreover, due to its interaction at PPARc, CBD was observed to stimulate hippocampal neurogenesis. All these findings report the inescapable role of this receptor in mediating CBD actions, here reported.

Read the Full Article

Share This:

Share on Twitter Share on Facebook Share on LinkedIn Share on Email
NextCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptorsNext

Conditions:

  • Batten Disease, Inflammation, Neuro-protective and Neuro-generative

Research Information:

Research Keywords:

  • Amyloid beta-Peptides/metabolism, Animals, Astrocytes/cytology, Astrocytes/metabolism, Binding Sites, Brain/metabolism, Cannabidiol/pharmacology, Hippocampus/metabolism, Inflammation/metabolism, Male, Neurogenesis, Neurons/metabolism, Neurons/pathology, Nitric Oxide/metabolism, PPAR gamma/metabolism, Protein Binding, Protein Structure, rats, Sprague-Dawley, Tertiary, Time Factors

Search the Research Library >

Follow Us:

Facebook Twitter Youtube

REGISTER WITH THE RoC TODAY!

Realm of Caring focuses on research, education, building community, and improving quality of life. We are an educational resource for consumers, physicians, scientists, governments and the media.
Register now
  • 5040 Corporate Plaza Drive, Suite 7R, Colorado Springs, CO 80919
  • 719-347-5400
  • info@realmofcaring.org

Copyright © 2021 / Realm of Caring Foundation, Inc

  • Privacy
  • Disclaimer